3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Psychotic Disorders in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 9 (47.37) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abel, KM; Bloemen, OJ; Booij, J; De Haan, L; De Koning, MB; Linszen, DH; Van Amelsvoort, TA; Van Duin, ED | 1 |
| Boerner, R; Dresel, S; Frodl, T; Gründer, G; Hahn, K; la Fougère, C; Meisenzahl, EM; Möller, HJ; Scheuerecker, J; Schmitt, G; Schwarz, M; Stauss, J | 1 |
| Alonso, A; Álvarez, E; Arranz, B; Camacho, V; Carrió, I; Corripio, I; Dueñas, R; Escartí, MJ; Ferrer, M; Grasa, EM; Pérez, V; Portella, MJ; Safont, G; San, L; Sauras, RB | 1 |
| Alonso, A; Alvarez, E; Arranz, B; Camacho, MV; Carrió, I; Catafau, AM; Corripio, I; Dueñas, R; Escartí, MJ; Grasa, E; Pérez, V; Portella, MJ; Safont, G; San, L; Sauras, RB | 1 |
| Bloemen, OJ; Booij, J; de Haan, L; de Koning, MB; Gleich, T; Linszen, DH; Meijer, J; van Amelsvoort, TA | 1 |
| Dresel, S; Frodl, T; Hahn, K; Meisenzahl, EM; Möller, HJ; Preuss, UW; Rossmüller, B; Schmitt, GJ; Tatsch, K | 1 |
| Aguilar, Y; Alvarez, E; Carrió, I; Catafau, AM; Corripio, I; Mena, E; Perez, V; Puigdemont, D | 1 |
| Booij, J; de Haan, L; Lavalaye, J; Linszen, D | 1 |
| Alvarez, E; Carrió, I; Catafau, AM; Corripio, I; Mena, E; Pérez, V | 1 |
| Alvarez, E; Carrió, I; Catafau, AM; Corripio, I; Martin, JC; Pérez, V; Schotte, A | 1 |
| Busatto, GF; Costa, DC; Ell, PJ; Kerwin, RW; Pilowsky, LS; Verhoeff, NP | 1 |
| Costa, DC; Ell, PJ; Moriarty, J; Ring, HA; Trimble, MR; Verhoeff, NP | 1 |
| Bauer, R; Dorndorf, W; Franz, M; Gallhofer, B; Jauss, M; Klett, R; Krack, P | 1 |
| Asenbaum, S; Brücke, T; Gössler, R; Kasper, S; Küfferle, B; Podreka, I; Tauscher, J; Topitz-Schratzberger, A; Vesely, C | 1 |
| Asenbaum, S; Brücke, T; Kasper, S; Küfferle, B; Podreka, I; Tauscher, J; Vesely, C | 1 |
| Dresel, S; Hahn, K; Mager, T; Meisenzahl, E; Möller, HJ; Rossmüller, B; Tatsch, K | 1 |
| Kapur, S; Seeman, P | 1 |
| Dresel, S; Frodl, T; Hahn, K; Mager, T; Meisenzahl, EM; Möller, HJ; Preuss, UW; Rossmüller, B; Schmitt, GJ; Tatsch, K | 1 |
| Abi-Dargham, A; Gelernter, J; Innis, RB; Kegeles, L; Laruelle, M; Martinez, D; van Dyck, CH | 1 |
7 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Psychotic Disorders
| Article | Year |
|---|---|
Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzamides; Corpus Striatum; Dose-Response Relationship, Drug; Female; Humans; Iodine Radioisotopes; Male; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia; Severity of Illness Index; Statistics, Nonparametric; Sulpiride; Tomography, Emission-Computed, Single-Photon | 2008 |
Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis.
Topics: Adult; alpha-Methyltyrosine; Benzamides; Case-Control Studies; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopaminergic Neurons; Female; Functional Neuroimaging; Homovanillic Acid; Humans; Male; Prolactin; Psychotic Disorders; Pyrrolidines; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; Tyrosine 3-Monooxygenase | 2013 |
Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine.
Topics: Adult; Aged; Antipsychotic Agents; Benzamides; Benzodiazepines; Contrast Media; Corpus Striatum; Dopamine D2 Receptor Antagonists; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 2002 |
Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
Topics: Adult; Antipsychotic Agents; Benzamides; Drug Resistance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Neostriatum; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Single-Blind Method; Thiazoles; Tomography, Emission-Computed, Single-Photon; Treatment Failure | 2005 |
Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study.
Topics: Adult; Antipsychotic Agents; Basal Ganglia; Benzamides; Cerebral Cortex; Dopamine D2 Receptor Antagonists; Female; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Isoxazoles; Male; Middle Aged; Neostriatum; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrrolidines; Remoxipride; Risperidone; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 1995 |
IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol.
Topics: Adult; Antipsychotic Agents; Benzamides; Clozapine; Dibenzothiazepines; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Middle Aged; Neostriatum; Psychotic Disorders; Pyrrolidines; Quetiapine Fumarate; Receptors, Dopamine D2; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 1997 |
D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Benzodiazepines; Brain; Brain Chemistry; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 2000 |
12 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Psychotic Disorders
| Article | Year |
|---|---|
Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis.
Topics: Acoustic Stimulation; Adolescent; Adult; Basal Ganglia; Benzamides; Case-Control Studies; Contrast Media; Dopamine; Dopaminergic Neurons; Female; Humans; Male; Prepulse Inhibition; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Receptors, Dopamine D3; Reflex, Startle; Risk Assessment; Risk Factors; Tomography, Emission-Computed, Single-Photon; Young Adult | 2014 |
Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: an in vivo SPECT study.
Topics: Adolescent; Adult; Analysis of Variance; Benzamides; Cannabis; Corpus Striatum; Dopamine Antagonists; Female; Humans; Male; Prospective Studies; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Statistics, Nonparametric; Tomography, Emission-Computed, Single-Photon; Young Adult | 2011 |
Density of striatal D2 receptors in untreated first-episode psychosis: an I123-IBZM SPECT study.
Topics: Adult; Benzamides; Biomarkers; Corpus Striatum; Female; Humans; Iodine Radioisotopes; Male; Predictive Value of Tests; Prospective Studies; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Young Adult | 2011 |
Comfort, self-confidence, safety, and dopamine D2 receptor occupancy by antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzamides; Female; Humans; Male; Personal Satisfaction; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Safety; Schizophrenia; Schizophrenic Psychology; Self Efficacy; Tomography, Emission-Computed, Single-Photon | 2005 |
Striatal D2 receptor binding as a marker of prognosis and outcome in untreated first-episode psychosis.
Topics: Adult; Antipsychotic Agents; Benzamides; Biomarkers; Case-Control Studies; Female; Humans; Male; Neostriatum; Prognosis; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2006 |
Dopamine D2 receptor occupancy by risperidone: implications for the timing and magnitude of clinical response.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzamides; Brief Psychiatric Rating Scale; Corpus Striatum; Dominance, Cerebral; Female; Frontal Lobe; Humans; Male; Middle Aged; Occipital Lobe; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2006 |
Striatal dopamine receptor binding in epileptic psychoses.
Topics: Adult; Basal Ganglia; Benzamides; Binding Sites; Epilepsy; Humans; Male; Middle Aged; Occipital Lobe; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 1994 |
Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Basal Ganglia; Benperidol; Benzamides; Dopamine Antagonists; Frontal Lobe; Haloperidol; Humans; Iodine Radioisotopes; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 1996 |
Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzamides; Brain Mapping; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed, Single-Photon | 1996 |
In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Benzodiazepines; Case-Control Studies; Corpus Striatum; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Male; Olanzapine; Pirenzepine; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine; Risperidone; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 1999 |
Schizophrenia: more dopamine, more D2 receptors.
Topics: Benzamides; Dopamine; Dopamine Antagonists; Models, Biological; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia | 2000 |
The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans.
Topics: Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Benzamides; Carrier Proteins; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Genotype; Humans; Iodine Radioisotopes; Membrane Glycoproteins; Membrane Transport Proteins; Minisatellite Repeats; Neostriatum; Nerve Tissue Proteins; Phenotype; Polymorphism, Genetic; Psychotic Disorders; Pyrrolidines; Radiopharmaceuticals; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 2001 |